List of Excipients in API avatrombopag maleate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing avatrombopag maleate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| AkaRx Inc | DOPTELET | avatrombopag maleate | 71369-020 | CELLULOSE, MICROCRYSTALLINE | 2027-07-28 |
| AkaRx Inc | DOPTELET | avatrombopag maleate | 71369-020 | CROSPOVIDONE | 2027-07-28 |
| AkaRx Inc | DOPTELET | avatrombopag maleate | 71369-020 | FERRIC OXIDE YELLOW | 2027-07-28 |
| AkaRx Inc | DOPTELET | avatrombopag maleate | 71369-020 | LACTOSE MONOHYDRATE | 2027-07-28 |
| AkaRx Inc | DOPTELET | avatrombopag maleate | 71369-020 | MAGNESIUM STEARATE | 2027-07-28 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for avatrombopag maleate
Excipient focus: CELLULOSE, MICROCRYSTALLINE
avatrombopag maleate drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| AkaRx Inc | avatrombopag maleate | 71369-020 |
| >Company | >Ingredient | >NDC |
avatrombopag maleate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
avatrombopag maleate drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| AkaRx Inc | avatrombopag maleate | 71369-020 |
| >Company | >Ingredient | >NDC |
avatrombopag maleate drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
avatrombopag maleate drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| AkaRx Inc | avatrombopag maleate | 71369-020 |
| >Company | >Ingredient | >NDC |
avatrombopag maleate drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
avatrombopag maleate drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| AkaRx Inc | avatrombopag maleate | 71369-020 |
| >Company | >Ingredient | >NDC |
avatrombopag maleate drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
avatrombopag maleate drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| AkaRx Inc | avatrombopag maleate | 71369-020 |
| >Company | >Ingredient | >NDC |
avatrombopag maleate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
avatrombopag maleate drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| AkaRx Inc | avatrombopag maleate | 71369-020 |
| >Company | >Ingredient | >NDC |
avatrombopag maleate drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
avatrombopag maleate drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| AkaRx Inc | avatrombopag maleate | 71369-020 |
| >Company | >Ingredient | >NDC |
avatrombopag maleate drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
avatrombopag maleate drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| AkaRx Inc | avatrombopag maleate | 71369-020 |
| >Company | >Ingredient | >NDC |
avatrombopag maleate drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
avatrombopag maleate drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| AkaRx Inc | avatrombopag maleate | 71369-020 |
| >Company | >Ingredient | >NDC |
avatrombopag maleate drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
avatrombopag maleate drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| AkaRx Inc | avatrombopag maleate | 71369-020 |
| >Company | >Ingredient | >NDC |
avatrombopag maleate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
